Colon Cancer Increasingly Striking the Young Worldwide
FRIDAY, May 17, 2019 -- The rise in colon cases among younger adults thats been seen in the United States is also occurring in wealthier nations worldwide, new research shows.
In the decade leadin
FDA Approves Ruzurgi
FDA Approves Ruzurgi (amifampridine) for Children with Lambert-Eaton Myasthenic Syndrome
May 06, 2019 -- The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myast
FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients
RALEIGH, N.C. – May 13, 2019 – Merz Americas announced today that the U.S. Food and Drug Administra
FRIDAY, May 10, 2019 -- Physicians are aware of patients difficulty with affording medical care and consider out-of-pocket costs in their decision making, according to an article published in a supplement to the May 7 issue of the Annals of Internal Medic
Health Tip: Benefits of Fitness Boxing
-- Fitness boxing is a popular way for adults to stay fit.
Unlike regular boxing, fitness boxing does not involve sparring, so there is no risk of head trauma, says Harvard Medical School. Instead, participants t
FDA Approves New Treatments Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) for Heart Disease Caused by Transthyretin Mediated Amyloidosis
May 06, 2019 -- On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and